Stage-specific antileishmanial activity and selectivity of cynarin, apigenin, and luteolin against Leishmania tropica in vitro models.
Leishmaniasis is a parasitic disease caused by Leishmania species and constitutes a significant global public health concern. Pentavalent antimonials, the current first-line therapy for cutaneous leishmaniasis, are limited by toxicity, high cost, and emerging drug resistance. This study aims to evaluate the antipromast...